This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1eb2

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1eb2.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:1eb2.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1eb2| PDB=1eb2 | SCENE= }}
{{STRUCTURE_1eb2| PDB=1eb2 | SCENE= }}
-
'''TRYPSIN INHIBITOR COMPLEX (BPO)'''
+
===TRYPSIN INHIBITOR COMPLEX (BPO)===
-
==Overview==
+
<!--
-
In silico screening of combinatorial libraries prior to synthesis promises to be a valuable aid to lead discovery. PRO_SELECT, a tool for the virtual screening of libraries for fit to a protein active site, has been used to find novel leads against the serine protease factor Xa. A small seed template was built upon using three iterations of library design, virtual screening, synthesis, and biological testing. Highly potent molecules with selectivity for factor Xa over other serine proteases were rapidly obtained.
+
The line below this paragraph, {{ABSTRACT_PUBMED_11881991}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 11881991 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_11881991}}
==About this Structure==
==About this Structure==
Line 30: Line 34:
[[Category: Inhibitor]]
[[Category: Inhibitor]]
[[Category: Serine protease]]
[[Category: Serine protease]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 14:53:25 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 1 00:26:08 2008''

Revision as of 21:26, 30 June 2008

Image:1eb2.png

Template:STRUCTURE 1eb2

TRYPSIN INHIBITOR COMPLEX (BPO)

Template:ABSTRACT PUBMED 11881991

About this Structure

1EB2 is a Single protein structure of sequence from Bos taurus. Full crystallographic information is available from OCA.

Reference

PRO_SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors., Liebeschuetz JW, Jones SD, Morgan PJ, Murray CW, Rimmer AD, Roscoe JM, Waszkowycz B, Welsh PM, Wylie WA, Young SC, Martin H, Mahler J, Brady L, Wilkinson K, J Med Chem. 2002 Mar 14;45(6):1221-32. PMID:11881991

Page seeded by OCA on Tue Jul 1 00:26:08 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1eb2"
Personal tools